Mass Blackout

Drugs For Treatment Of Tetanus

List of drugs/medicine used for Tetanus

Advertisement

Are you searching for medications to treat 'Tetanus'? Welcome to this section, which serves as a repository for medications that are relevant to the treatment of Tetanus. The page includes both the generic and brand names and can be an invaluable resource for healthcare professionals and individuals who wish to get an insight on different medication options. Click on a medication below to view details including brand names, prices, dosages, side effects, and administration guidelines. Additionally, a FAQs section is available for each medication, addressing popular inquiries and providing deeper insights into its use for Tetanus management. We recommend consulting your doctor to verify the information presented on this page or for any additional clarifications.

Advertisement

Brand Names and Generic Names of Drugs for Treatment of Tetanus DPT- Diphtheria, Tetanus and Pertussis Vaccine

DPT- Diphtheria, Tetanus and Pertussis Vaccine is an active immunization, prescribed for diphtheria, pertussis (whooping cough) and tetanus.

Haemophilus B Conjugate Vaccine

Haemophilus B Conjugate Vaccine is an immunization agent, prescribed as an active immunization of infants and children for Haemophilus influenza type B bacteria and/or diphtheria, tetanus, and pertussis infections.

Advertisement

Pediarix Vaccine

Pediarix Vaccine is an immunization agent, prescribed for diphtheria, tetanus, pertussis, hepatitis B and polio infections in infants and children.

Tdap

Tdap is a vaccine, prescribed for tetanus, diphtheria, and pertussis infections.

Tetanus Toxoid

Tetanus Toxoid is an immunization vaccine, prescribed for tetanus (also known as lockjaw), which may cause a serious illness.

Trade Names :

More...

Advertisement

Tetanus-Diphtheria-Acellular Pertussis (Tdap)

Tetanus-Diphtheria-Acellular Pertussis (Tdap) is an immunization agent, prescribed for tetanus, diphtheria, and pertussis as a single dose in persons 11 to 64 years.

Suggested Readings on Tetanus

The Central nervous system consists of the brain, the spinal cord, and the body's nerve network. This complex system is based on one kind of cell the neurons.

Tattoos are a rage among college students who sport it for the 'cool dude' or 'cool babe' look

↑

Drugs For Treatment Of Diphtheria

Are you searching for medications to treat 'Diphtheria'? Welcome to this section, which serves as a repository for medications that are relevant to the treatment of Diphtheria. The page includes both the generic and brand names and can be an invaluable resource for healthcare professionals and individuals who wish to get an insight on different medication options. Click on a medication below to view details including brand names, prices, dosages, side effects, and administration guidelines. Additionally, a FAQs section is available for each medication, addressing popular inquiries and providing deeper insights into its use for Diphtheria management. We recommend consulting your doctor to verify the information presented on this page or for any additional clarifications. Advertisement Brand Names and Generic Names of Drugs for Treatment of Diphtheria Clindamycin Clindamycin is an antibiotic, prescribed for certain types of bacterial infections, including infections of the lungs, skin, blood, female reproductive organs and internal organs. Trade Names : More... DPT- Diphtheria, Tetanus and Pertussis Vaccine DPT- Diphtheria, Tetanus and Pertussis Vaccine is an active immunization, prescribed for diphtheria, pertussis (whooping cough) and tetanus. Advertisement Erythromycin Erythromycin is an antibiotic, prescribed for certain types of bacterial infections such as bronchitis, diphtheria, legionnaires' disease, pertussis etc. Trade Names : More... Haemophilus B Conjugate Vaccine Haemophilus B Conjugate Vaccine is an immunization agent, prescribed as an active immunization of infants and children for Haemophilus influenza type B bacteria and/or diphtheria, tetanus, and pertussis infections. Pediarix Vaccine Pediarix Vaccine is an immunization agent, prescribed for diphtheria, tetanus, pertussis, hepatitis B and polio infections in infants and children. Advertisement Tdap Tdap is a vaccine, prescribed for tetanus, diphtheria, and pertussis infections. Tetanus-Diphtheria-Acellular Pertussis (Tdap) Tetanus-Diphtheria-Acellular Pertussis (Tdap) is an immunization agent, prescribed for tetanus, diphtheria, and pertussis as a single dose in persons 11 to 64 years. Search for Drugs: For Related Medical Condition Suggested Readings on Diphtheria Prior to 1974, there was no organized immunization programme. Expanded programme on immunization (EPI) was introduced in 1974 by the WHO and adopted by India in 1978 without measles vaccination. Measles-Mumps-Rubella - One dose is given to adults born in 1957 or later and not previously immunized. A second dose may be required in some work or school settings. Tetanus (or Lockjaw) is a serious preventable infection that can affect the muscles and nerves and results from contamination of wound. The vaccine against Tetanus can prevent the infection. Tracheostomy-Tracheostomy is a surgical procedure of making an incision into the trachea (windpipe) for creating a surgical airway by way of a temporary or permanent opening. Calculate the ideal weight of your baby with Medindia's Infant weight calculator. This scoring system is used to identify babies at risk for complications or bad outcome from delivery during the early minutes of their life and determine if any medical intervention is needed immediately. Medindia offers a milestone chart for the growing child, by which we can determine the activities of the baby at various stages of the growth. Nutritional Assessment Calculator helps to find out if you child is undernourished or malnourished.

GlaxoSmithKline, In Barnard Castle, Reports Ten Per Cent Revenue Rise

A DRUGS firm is celebrating business success after recording ten per cent growth on the prior financial year.

GlaxoSmithKline (GSK) which has a factory on Harmire Road, in Barnard Castle, said it had made £33,754m turnover at the end of 2019 with business leaders hailing its 'excellent progress'.

The firm is one of the region's largest employers and has recently joined forces with a fellow pharmaceutical company to develop a vaccine in the fight against coronavirus.

GSK said the new collaboration with French company, Sanofi, marked a significant milestone in GSK's and Sanofi's ongoing contributions to help fight coronavirus.

It will contribute its pandemic adjuvant technology to the collaboration whilst Sanofi will deliver its S-protein Covid-19 antigen, which is based on recombinant DNA technology.

The companies plan to initiate phase one of clinical trials in the second half of 2020 and if successful and subject to regulatory considerations, aim to complete the development required for availability by the second half of 2021.

The firm said the collaboration is part of its 'good performance' and said the sales growth reflects strong underlying performance and additional impact from increased demand including stock building for many products.

In the fight against coronavirus, its scientists are also working with international organisations including the World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI) and governments worldwide.

Emma Walmsley, chief executive officer of GSK said: "GSK delivered a good performance in 2019 with growth in sales and earnings, together with strong cash generation.

"We also made excellent progress in all three of our long-term priorities, innovation, performance and trust, strengthening our pipeline, improving operational execution and reshaping the company.

"In 2020, our first priority remains innovation, to progress our pipeline and support new product launches. Recent data readouts underpin our decision to further increase investment in research and development and these new products.

"At the same time, we are again focused on operational execution, including delivering a successful integration in consumer healthcare, and we are also preparing for the future, starting a new two-year programme to get GSK ready for separation.

"All of this aims to support future growth, deliver significant value creation, and set up two new leading companies in biopharma and consumer healthcare, each with the opportunity to improve the health of hundreds of millions of people."

Recordings said vaccines turnover grew 21 per cent to £7,157m, primarily driven by growth in sales of Shingrix.

Meningitis vaccines also contributed to growth mainly due to Bexsero demand and share gains in the United States together with stronger demand in international produects.

Established vaccines revenue grew two per cent to £3,788m, reflecting growth in Boostrix, Hepatitis, Synflorix and Infanrix/Pediarix, partly offset by lower Cervarix sales in international and supply constraints in MMRV vaccines.

---